Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330004 · ClinicalTrials.gov registry record
Blood Pressure Change and Outcome
A clinical trial, sponsored by Renal Research Institute.
- Completed
- Registry status
- 12,695
- Enrollment target
NCT01330004 is a clinical trial that has completed, run by Renal Research Institute. The registered enrollment target is 12,695 participants.
The verdict
NCT01330004 has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 12,695 participants
- Enrollment target
Study Summary
Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been previously studied in dialysis population. The investigators aim to understand how both blood pressure levels and blood pressure changes over time predict patient survival.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,695 participants |
| Start Date | 1999-01 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01330004
The ClinicalTrials.gov registry entry for NCT01330004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12,695 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01330004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01330004 about?
NCT01330004 is a clinical study titled "Blood Pressure Change and Outcome". Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been...
What is the current status of trial NCT01330004?
This trial is currently completed. The enrollment target is 12,695 participants. The study started on 1999-01. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01330004?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.